Gastrointestinal Agents Concept

subject area of

• 10-biomarker algorithm to identify irritable bowel syndrome  Academic Article
• A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study  Academic Article
• A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease  Academic Article
• A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon   antibody, in patients with moderate to severe Crohn's disease  Academic Article
• A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease  Academic Article
• A randomised placebo controlled trial of pegylated interferon   in active ulcerative colitis  Academic Article
• ACG and CAG Clinical Guideline: Management of Dyspepsia  Academic Article
• AST-120 (Spherical Carbon Adsorbent) in the Treatment of Perianal Fistulae in Mild-to-Moderate Crohnʼs Disease  Academic Article
• Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial  Academic Article
• An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease  Academic Article
• An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.  Academic Article
• Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial  Academic Article
• Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis  Academic Article
• Austrian infliximab experience in Crohn's disease  Academic Article
• BDNF and PDE4, but not the GRPR, Regulate Viability of Human Medulloblastoma Cells  Academic Article
• C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I  Academic Article
• Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease  Academic Article
• Change in Erythrocyte Mean Corpuscular Volume During Combination Therapy with Azathioprine and Infliximab Is Associated with Mucosal Healing  Academic Article
• Cisapride: The Problem of the Heart  Academic Article
• Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus  Academic Article
• Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues  Academic Article
• Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab  Academic Article
• Commonly Used Preparations for Colonoscopy: Efficacy, Tolerability and Safety – A Canadian Association of Gastroenterology Position Paper  Academic Article
• Current Guidelines for Dyspepsia Management  Academic Article
• Current Guidelines on Stress Ulcer Prophylaxis  Academic Article
• Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease  Academic Article
• Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?  Academic Article
• Does the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey‐based study  Academic Article
• Drug monitoring of biologics in inflammatory bowel disease  Academic Article
• Dyspepsia  Academic Article
• Dyspepsia  Academic Article
• Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis  Academic Article
• Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis  Academic Article
• Efficacy and tolerability of tegaserod in constipation dominant irritable bowel syndrome.  Academic Article
• Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis  Academic Article
• Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study  Academic Article
• Eradication of Helicobacter pylori for non-ulcer dyspepsia  Academic Article
• Eradication of Helicobacter pylori for non-ulcer dyspepsia  Academic Article
• Eradication of Helicobacter pylori for non-ulcer dyspepsia  Academic Article
• Eradication of Helicobacter pylori for non-ulcer dyspepsia.  Academic Article
• Eradication of helicobacter pylori for non-ulcer dyspepsia.  Academic Article
• Erythromycin for the prevention and treatment of feeding intolerance in preterm infants  Academic Article
• Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments  Academic Article
• Exposure–efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn’s Disease  Academic Article
• Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey  Academic Article
• Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn’s Disease Treated With Infliximab [Remicade®] or Conventional Therapy  Academic Article
• Fontolizumab in moderate to severe Crohnʼs disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study  Academic Article
• Gastro-oesophageal reflux disease.  Academic Article
• Gastro-oesophageal reflux disease.  Academic Article
• Gastro-oesophageal reflux disease.  Academic Article
• Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia.  Academic Article
• Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism  Academic Article
• Infliximab  Academic Article
• Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection  Academic Article
• Infliximab in der Therapie der Colitis ulcerosa  Academic Article
• Infliximab in der Therapie des Morbus Crohn - ein praktischer Leitfaden: aktualisierter ÖGGH-Konsensus der Arbeitsgruppe Chronisch-entzündliche Darmerkrankungen der ÖGGH  Academic Article
• Infliximab in the Treatment of Crohn's Disease - a Practical Approach  Academic Article
• Infliximab or Cyclosporine as Rescue Therapy in Hospitalized Patients with Steroid-Refractory Ulcerative Colitis: A Retrospective Observational Study  Academic Article
• Initial management strategies for dyspepsia  Academic Article
• Initial management strategies for dyspepsia  Academic Article
• Initial management strategies for dyspepsia  Academic Article
• Initial management strategies for dyspepsia.  Academic Article
• Initial management strategies for dyspepsia.  Academic Article
• Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal motor disorders  Academic Article
• Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial  Academic Article
• Letter: mucosal healing is associated with improved long-term outcomes in Crohn's disease - authors' reply  Academic Article
• Letter: recommendations for the management of latent tuberculosis infection in IBD patients may not be applicable in all settings - author's reply  Academic Article
• Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies  Academic Article
• Management of reflux-related symptoms  Academic Article
• Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis  Academic Article
• New Pharmacologic Approaches in Gastroesophageal Reflux Disease  Academic Article
• New Pharmacologic Approaches in Gastroesophageal Reflux Disease  Academic Article
• Pancreatic Enzyme Supplements Are Not Effective for Relieving Abdominal Pain in Patients with Chronic Pancreatitis: Meta-Analysis and Systematic Review of Randomized Controlled Trials  Academic Article
• Pharmacological interventions for non-ulcer dyspepsia  Academic Article
• Pharmacological interventions for non-ulcer dyspepsia  Academic Article
• Pharmacological interventions for non-ulcer dyspepsia  Academic Article
• Pharmacological interventions for non-ulcer dyspepsia  Academic Article
• Pharmacological interventions for non-ulcer dyspepsia.  Academic Article
• Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study  Academic Article
• Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease  Academic Article
• Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONICpost hocanalysis  Academic Article
• Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis  Academic Article
• Recommendations on Chronic Constipation (including Constipation Associated with Irritable Bowel Syndrome) Treatment  Academic Article
• Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis  Academic Article
• Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors  Academic Article
• Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis  Academic Article
• Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease  Academic Article
• Review article: current treatment options and management of functional dyspepsia  Academic Article
• Review article: defining remission in ulcerative colitis  Academic Article
• Review article: infliximab for Crohn’s disease treatment - shifting therapeutic strategies after 10 years of clinical experience  Academic Article
• Segundo consenso europeo basado en evidencia sobre el diagnóstico y manejo de la colitis ulcerosa crónica idiopática. Parte 2: tratamiento actual (versión española)  Academic Article
• Severe Colitis in Children  Academic Article
• Should we step‑up or step‑down in the treatment of new‑onset dyspepsia in primary care?  Academic Article
• Sudden cardiac death & the Reverse Dodo Verdict.  Academic Article
• Systematic Review  Academic Article
• Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids  Academic Article
• Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease  Academic Article
• Systematic review: antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia  Academic Article
• Systematic review: persistence and severity in gastroesophageal reflux disease  Academic Article
• The Effects of Infliximab Therapy on Health-Related Quality of Life in Ulcerative Colitis Patients  Academic Article
• The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohnʼs and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?  Academic Article
• The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium  Academic Article
• The Second Canadian Gastroesophageal Reflux Disease Consensus: Moving Forward to New Concepts  Academic Article
• The intestinal microbiome, probiotics and prebiotics in neurogastroenterology  Academic Article
• The minimal detectable change cannot reliably replace the minimal important difference  Academic Article
• The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13  Academic Article
• Tracking gastrointestinal transit of solids in aged rats as pharmacological models of chronic dysmotility  Academic Article
• Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents  Academic Article
• Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease  Academic Article
• Update from the Canadian Dyspepsia Working Group.  Academic Article
• Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease  Academic Article
• Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome  Academic Article
• Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC  Academic Article
• Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn’s Disease  Academic Article